Hiroyasu Ito

Title: Hiroyasu Ito: Innovator in Wound Healing Technologies

Introduction

Hiroyasu Ito is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of wound healing. His innovative approach combines antibiotics with specific ingredients that enhance the healing process without compromising the antibiotic's effectiveness.

Latest Patents

Hiroyasu Ito holds a patent for the "Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing." This patent describes pharmaceutical compositions that include an antibiotic along with ingredients that counteract the antibiotic's negative effects on wound healing. The compositions are designed for topical administration and include an imidazoquinoline with toll-like receptor 7 (TLR7) ligand activity, an immunostimulatory K-type CpG oligodeoxynucleotide (ODN) with an unmethylated CpG motif, and a surfactant. The methods outlined in the patent aim to accelerate wound healing for wounds located in the skin or the eye.

Career Highlights

Hiroyasu Ito is affiliated with the National Institutes of Health, a component of the U.S. Department of Health & Human Services. His work at this prestigious institution has allowed him to focus on innovative research that bridges the gap between pharmaceutical science and practical medical applications.

Collaborations

Hiroyasu Ito collaborates with Dennis M. Klinman, a fellow researcher whose expertise complements Ito's work in wound healing technologies.

Conclusion

Hiroyasu Ito's contributions to the field of wound healing through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly improve patient outcomes in wound care.